
    
      1. The objective of this study is to evaluate the potential of DSXS to suppress HPA axis
           function in patients with moderate to severe plaque psoriasis

        2. To evaluate the efficacy parameters, pharmacokinetics and adverse event (AE) profile of
           DSXS
    
  